array:21 [
  "pii" => "X2013251409004572"
  "issn" => "20132514"
  "doi" => "10.3265/Nefrologia.2009.29.3.5327.en.full"
  "estado" => "S300"
  "fechaPublicacion" => "2009-06-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia (English Version). 2009;29:193-5"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 4024
    "formatos" => array:3 [
      "EPUB" => 242
      "HTML" => 3213
      "PDF" => 569
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:17 [
      "pii" => "X0211699509004575"
      "issn" => "02116995"
      "doi" => "10.3265/Nefrologia.2009.29.3.5327.en.full"
      "estado" => "S300"
      "fechaPublicacion" => "2009-06-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2009;29:193-5"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 8958
        "formatos" => array:3 [
          "EPUB" => 255
          "HTML" => 8056
          "PDF" => 647
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "titulo" => "Biobancos: una nueva herramienta para la investigación clínica"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "193"
            "paginaFinal" => "195"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Biobanks: a new tool for clinical research"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig1"
            "etiqueta" => "Fig. 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "copyright" => "Elsevier España"
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "169108_mostrarfile3.jpg"
                "Alto" => 426
                "Ancho" => 1750
                "Tamanyo" => 153515
              ]
            ]
            "descripcion" => array:1 [
              "es" => "Dificultades asociadas con la puesta en marcha de los biobancos"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "F Liaño, AM Torres"
            "autores" => array:2 [
              0 => array:2 [
                "Iniciales" => "F"
                "apellidos" => "Liaño"
              ]
              1 => array:2 [
                "Iniciales" => "AM"
                "apellidos" => "Torres"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "X2013251409004572"
          "doi" => "10.3265/Nefrologia.2009.29.3.5327.en.full"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409004572?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509004575?idApp=UINPBA000064"
      "url" => "/02116995/0000002900000003/v0_201502091409/X0211699509004575/v0_201502091409/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251409004556"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.2009.29.3.5290.en.full"
    "estado" => "S300"
    "fechaPublicacion" => "2009-06-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2009;29:196-202"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4383
      "formatos" => array:3 [
        "EPUB" => 236
        "HTML" => 3648
        "PDF" => 499
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "titulo" => "FGF23 in chronic kidney disease and kidney post-transplant patients"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "196"
          "paginaFinal" => "202"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "El FGF23 en la insuficiencia renal crónica y el post-transplante renal"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig1"
          "etiqueta" => "Fig. 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier España"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "17018078_f1_p198.jpg"
              "Alto" => 337
              "Ancho" => 398
              "Tamanyo" => 16798
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Armando Luis Negri"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Armando Luis"
              "apellidos" => "Negri"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699509004559"
        "doi" => "10.3265/Nefrologia.2009.29.3.5290.en.full"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509004559?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409004556?idApp=UINPBA000064"
    "url" => "/20132514/0000002900000003/v0_201502091629/X2013251409004556/v0_201502091629/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251409004580"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.2009.29.3.5326.en.full"
    "estado" => "S300"
    "fechaPublicacion" => "2009-06-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2009;29:185-92"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4287
      "formatos" => array:3 [
        "EPUB" => 239
        "HTML" => 3523
        "PDF" => 525
      ]
    ]
    "en" => array:9 [
      "idiomaDefecto" => true
      "titulo" => "Strategies for renal health: a project of the Spanish Society of Nephrology"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "185"
          "paginaFinal" => "192"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "ESTRATEGIAS EN SALUD RENAL: UN PROYECTO DE LA SOCIEDAD ESPAÑOLA DE NEFROLOGIA."
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => " Grupo de Acción Estratégica de la S.E.N., A Martínez Castelao, ALM de Francisco, JL Górriz, R Alcázar, L. Orte"
          "autores" => array:6 [
            0 => array:1 [
              "apellidos" => "Grupo de Acción Estratégica de la S.E.N."
            ]
            1 => array:2 [
              "Iniciales" => "A"
              "apellidos" => "Martínez Castelao"
            ]
            2 => array:2 [
              "nombre" => "ALM"
              "apellidos" => "de Francisco"
            ]
            3 => array:2 [
              "Iniciales" => "JL"
              "apellidos" => "Górriz"
            ]
            4 => array:2 [
              "Iniciales" => "R"
              "apellidos" => "Alcázar"
            ]
            5 => array:2 [
              "Iniciales" => "L."
              "apellidos" => "Orte"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699509004583"
        "doi" => "10.3265/Nefrologia.2009.29.3.5326.en.full"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509004583?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409004580?idApp=UINPBA000064"
    "url" => "/20132514/0000002900000003/v0_201502091629/X2013251409004580/v0_201502091629/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "titulo" => "Biobanks: a new tool for clinical research"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "193"
        "paginaFinal" => "195"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "F Liaño, AM Torres"
        "autores" => array:2 [
          0 => array:3 [
            "Iniciales" => "F"
            "apellidos" => "Liaño"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:3 [
            "Iniciales" => "AM"
            "apellidos" => "Torres"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Servicio de Nefrología y Departamento de Medicina, 1Biobanco del Hospital Universitario Ramón y Cajal-CIFRA, Madrid, Madrid, España, "
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
          1 => array:3 [
            "entidad" => "Servicio de Nefrología, 1Biobanco del Hospital Universitario Ramón y Cajal-CIFRA, Madrid, Madrid, España, "
            "etiqueta" => "<span class="elsevierStyleSup">b</span>"
            "identificador" => "affb"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Biobancos&#58; una nueva herramienta para la investigaci&#243;n cl&#237;nica"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:8 [
        "identificador" => "fig1"
        "etiqueta" => "Tab.  1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "16918078_t1_p195.jpg"
            "Alto" => 225
            "Ancho" => 826
            "Tamanyo" => 44167
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Difficulties involved in starting up biobanks"
        ]
      ]
    ]
    "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">INTRODUCTION</span></p><p class="elsevierStylePara">Biobank is an establishment containing biological samples that are associated with clinical information&#46; These samples are collected&#44; processed&#44; stored and managed according to quality criteria in order to make them available to serve society in a non-profit way with the aim of promoting biomedical investigation&#46;</p><p class="elsevierStylePara">As we infer from that definition&#44; biobanks are not the active agent for a single centre&#8217;s research&#59; rather&#44; they are complementary tools to facilitate the research of others&#46; Biobanks have come to be in the last five years&#59; their origin lies in the enormous growth of scientific production in biomedicine&#44; the need to coordinate basic and clinical studies by fostering cooperative models&#44; and the possibility of increasing the efficiency of informed consent so that the same biological material may serve for different studies&#46; Naturally&#44; all of this must be done according to criteria ensuring the quality and suitability of the stored samples&#44; and the ethical and legal requirements that guarantee citizens&#8217; rights&#46; Although these factors were already being taken into account be researchers&#44; they were not precisely regulated&#46; The combination of all of the above aspects led to the development of biobanks being considered a top-priority strategic need by both the EEC and&#44; at the Spanish national level&#44; the Carlos III Health Institute&#46;</p><p class="elsevierStylePara">Biobanks are intended to produce wealth through creating a mass of human <span class="elsevierStyleItalic">biological capital</span> intended to foster biomedical research and the promotion of health&#46; Samples must have an <span class="elsevierStyleItalic">overall quality</span> that is not only associated with their collection and storage conditions&#44; but also to their traceability and the precision and reliability of the clinical data associated with those samples&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Present and future of biobanks</span></p><p class="elsevierStylePara">At this time&#44; few biobanks are present in Spain&#46; Due to strategic initiatives by health authorities in this country&#44; an important development is foreseen in the near future&#46; The development of a biobank passes through the following phases&#58; defining its purpose&#44; predicting necessities&#44; obtaining funding&#44; installing infrastructure and preparing techniques&#44; preparing documentation&#44; implementing a management system&#44; and beginning operations&#46; In the medium term&#44; biobanks will begin to function as a network&#44; to maximise their potential on both the national and European levels&#46;</p><p class="elsevierStylePara">Biobanks could be intended to manage the biological material that would be necessary to develop a large project&#44; which would become increasingly associated with a high degree of specialisation &#40;National DNA Bank&#41;&#46; They could also attend to the needs of an institution - a hospital&#44; for example - or they could study a disease&#44; as is the case of the Spanish HIV BioBank&#46; These purposes would not be exclusive&#44; although in the future we would expect a tendency towards a certain degree of specialisation&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Bases for guaranteeing the effectiveness of biobanks</span></p><p class="elsevierStylePara">As mentioned previously&#44; biobanks are a very effective tool at the service of the scientific community&#46; When storing samples on a large scale&#44; complex technical procedures must necessarily be used for sample collection&#44; transport&#44; identification&#44; traceability maintenance&#44; storage at the proper temperature&#44; and for computerised data processing&#44; etc&#46; The bases that will guarantee the effectiveness of biobanks will comprise&#58;</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">Standardisation of procedures</span>&#58; the use of homogeneous&#44; well-defined protocols for sample collection&#44; processing&#44; conservation and storage will guarantee sample quality&#46; Well-defined standard notation of associated data will also create quality clinical information&#46; This will reflect the sample&#8217;s importance as biological capital&#44; since a sample with no associated information lacks value&#46; On the other hand&#44; the fact that the collection and storage of samples and associated clinical data will not be scattered among different groups&#44; centres&#44; collections&#44; etc&#46; will mean that all samples will share the same conditions and will be able to be compared with each other in different studies&#46;</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">Guaranteed sample traceability</span>&#44; by drawing on proper methodology for sample coding and identification&#44; which will guarantee its traceability at all times&#46;</p><p class="elsevierStylePara">- A <span class="elsevierStyleItalic">dynamic</span> and <span class="elsevierStyleItalic">effective management</span> by means of computer applications that allow us to list all of the processes to which samples and associated data have been submitted&#46;</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">The implementation of a quality management system</span> to make the organisation function effectively&#44; improving biobank customer satisfaction&#46;</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">Employment of qualified personnel</span> who will be exclusively dedicated to the operation of the biobank&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Bases for managing biobanks in Spain</span></p><p class="elsevierStylePara">The entire process that takes place from collecting the samples up to their use by researchers must be in accordance with applicable legislation&#44; which for biobanks is principally composed of&#58;</p><p class="elsevierStylePara">- Spanish Law 14&#47;2007 of 3 July regarding biomedical research&#44;<span class="elsevierStyleSup">1</span> which contemplates its origins and regulates its organisation&#44; functioning and records&#46; At present&#44; there is no developmental legislation to clarify it&#44; meaning that we must wait to know what conditions will be necessary for authorisation and for havinga national registry&#46; By law&#44; biobanks must guarantee the quality&#44; safety and traceability of the biological data and samples that they house&#46; Likewise&#44; they must guarantee protection of the rights of subjects who have donated biological material and who may be affected by the research&#46;</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">Organic Law 15&#47;1999 of 13 December regarding the Protection of Personal Data</span>&#46;<span class="elsevierStyleSup">2</span> This law must be applied to samples from identifiable subjects and to samples for which identification could be re-associated or decoded&#44; which are considered to be personal health-related data&#46; It requires guaranteeing confidentiality and the proper useof samples in the exclusive field of the approved research study&#46; The law does not apply to anonymous or irreversibly dissociated samples&#46;</p><p class="elsevierStylePara">Biobanks may be owned publicly or privately&#44; but for all cases they must be non-profit organisations&#46; Their organisational scheme must contain a scientific director and a file manager&#44; and in addition&#44; they must be attached to two external committees&#58; a scientific committee and an ethics committee&#46;</p><p class="elsevierStylePara">Legal considerations for using biological samples are different for biobanks and sample collections&#46; In both cases&#44; however&#44; the informed consent of the source subject is necessary in order to obtain the samples&#46; Given biobanks&#8217; mission of public service&#44; consent is granted in more wide-ranging terms&#46; This means it is not necessary to give details about the specific project in which the sample is to be used&#44; as would be the case for collections&#59; also&#44; there must be a clause regarding ceding the sample to third parties&#44; which is also impossible for normal data collecting without obtaining further consent&#46;</p><p class="elsevierStylePara">In this way&#44; samples can be kept indefinitely in a biobank and be at the scientific community&#8217;s disposal for future investigations that are not planned atthe moment the sample is taken&#46; The nature of the sample is respected in any case&#46;</p><p class="elsevierStylePara">Samples can be provided at no cost for use in research projects that have been approved by both the scientific and ethics sides&#46;</p><p class="elsevierStylePara">Only the minimum necessary quantity will be ceded&#46; Samples and associated data that are transferred will be kept anonymous or dissociated&#46; In the cession agreement&#44; the researcher will commit to not use the sample for any purpose other than that for which the sample was requested&#46; Likewise&#44; he&#47;she may not cede the sample to third parties&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Who benefits from biobank development&#63;</span></p><p class="elsevierStylePara">We expect that the benefits provided by biobanks will affect various segments of the population&#44; including the following&#58;</p><p class="elsevierStylePara">- Researchers&#58;</p><p class="elsevierStylePara">- Sample quality and organisation criteria allow them to carry out epidemiological studies under proper conditions&#46;<br></br>- Biobanks provide them with legal and ethical assessment and regulate the exchange of biological samples for investigation using standard procedures and transparent workings&#46;<br></br>- Biobanks act as an instrument for cooperative investigation that is multi-centre&#44; interdisciplinary and multi-sectorial&#46;<br></br>- Biobanks contribute to gaining new financing and patents for the Health System&#46;</p><p class="elsevierStylePara">- Patients&#58;</p><p class="elsevierStylePara">- By using biological samples&#44; researchers can develop biomarkers and target treatments that may lead to advances in prediction&#44; early diagnosis and disease treatment methods&#46;</p><p class="elsevierStylePara">- Society in general&#58;</p><p class="elsevierStylePara">- Biobanks may serve to develop diagnostic tools for preventing diseases&#46;<br></br>- They may identify risk factors if studies are carried out relating lifestyles or environmental factors with diseases&#46;<br></br>- The creation of <span class="elsevierStyleItalic">biological capital</span> will foster the creation of social wealth by acting as a factor promoting the development of the pharmaceutical industry&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Other considerations related to biobanks</span></p><p class="elsevierStylePara">Despite the positive aspects that biobanks can contribute&#44; summarised above&#44; their start-up is not free from difficulties&#44; some of which are shown in table 1&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Biobanks and Nephrology</span></p><p class="elsevierStylePara">Our speciality is not unaware of the need to have these tools at our disposal&#44; and in the future they will be completely necessary if we wish to deepen our study of the diseases that concern us&#46; In addition&#44; the possibility of real-time access to samples stored in biobanks will further increase nephrologists&#8217; capacity for research&#46; Given that the SEN &#40;Spanish Society of Nephrology&#41; has been a participative scientific society throughout its history&#44; we are certain that the development of biobanks will lead to better cooperation among us&#44; increasing our research potential&#44; and therefore our contribution to improving care for kidney disease patients&#46; Although we are still in a develop ment phase&#44;<span class="elsevierStyleSup">3</span> we are placing the Ramon y Cajal UH-CIFRA biobank at the disposal of Spanish nephrologists wishing to use it for their projects&#46;</p><p class="elsevierStylePara"><a href="grande&#47;16918078&#95;t1&#95;p195&#46;jpg" class="elsevierStyleCrossRefs"><img src="16918078_t1_p195.jpg" alt="Difficulties involved in starting up biobanks"></img></a></p><p class="elsevierStylePara">Table 1&#46; Difficulties involved in starting up biobanks</p>"
    "pdfFichero" => "P-E-S-A169-EN.pdf"
    "tienePdf" => true
    "multimedia" => array:1 [
      0 => array:8 [
        "identificador" => "fig1"
        "etiqueta" => "Tab.  1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "16918078_t1_p195.jpg"
            "Alto" => 225
            "Ancho" => 826
            "Tamanyo" => 44167
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Difficulties involved in starting up biobanks"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliography"
      "seccion" => array:1 [
        0 => array:1 [
          "bibliografiaReferencia" => array:3 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "LEY 14/2007, de 3 de julio, de Investigación biomédica. BOE 4 julio 2007, núm. 159: pág. 28826"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Ley Orgánica 15/1999, de 13 de diciembre, de Protección de Datos de Carácter Personal. BOE 14 diciembre 1999, núm. 298: pág. 43088"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "AM. Torres, MT. Tenorio, A. Candela, JM. Del Rey, A. Tejedor, L. Boscá, F. Liaño. Creación del Biobanco de Fracaso Renal Agudo de la Comunidad de Madrid: una herramienta para la nefrología española. Nefrología 2008; 28 (supl. 4): 30. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18457558" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000002900000003/v0_201502091629/X2013251409004572/v0_201502091629/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35429"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Editorials"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002900000003/v0_201502091629/X2013251409004572/v0_201502091629/en/P-E-S-A169-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409004572?idApp=UINPBA000064"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Biobanks: a new tool for clinical research
Biobancos: una nueva herramienta para la investigación clínica
F. Liañoa, AM. Torresb
a Servicio de Nefrología y Departamento de Medicina, 1Biobanco del Hospital Universitario Ramón y Cajal-CIFRA, Madrid, Madrid, España,
b Servicio de Nefrología, 1Biobanco del Hospital Universitario Ramón y Cajal-CIFRA, Madrid, Madrid, España,
Read
9143
Times
was read the article
2389
Total PDF
6754
Total HTML
Share statistics
 array:21 [
  "pii" => "X2013251409004572"
  "issn" => "20132514"
  "doi" => "10.3265/Nefrologia.2009.29.3.5327.en.full"
  "estado" => "S300"
  "fechaPublicacion" => "2009-06-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia &#40;English Version&#41;. 2009;29:193-5"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 4024
    "formatos" => array:3 [
      "EPUB" => 242
      "HTML" => 3213
      "PDF" => 569
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:17 [
      "pii" => "X0211699509004575"
      "issn" => "02116995"
      "doi" => "10.3265/Nefrologia.2009.29.3.5327.en.full"
      "estado" => "S300"
      "fechaPublicacion" => "2009-06-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2009;29:193-5"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 8958
        "formatos" => array:3 [
          "EPUB" => 255
          "HTML" => 8056
          "PDF" => 647
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "titulo" => "Biobancos&#58; una nueva herramienta para la investigaci&#243;n cl&#237;nica"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "193"
            "paginaFinal" => "195"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Biobanks&#58; a new tool for clinical research"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig1"
            "etiqueta" => "Fig. 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "copyright" => "Elsevier Espa&#241;a"
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "169108_mostrarfile3.jpg"
                "Alto" => 426
                "Ancho" => 1750
                "Tamanyo" => 153515
              ]
            ]
            "descripcion" => array:1 [
              "es" => "Dificultades asociadas con la puesta en marcha de los biobancos"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "F Lia&#241;o, AM Torres"
            "autores" => array:2 [
              0 => array:2 [
                "Iniciales" => "F"
                "apellidos" => "Lia&#241;o"
              ]
              1 => array:2 [
                "Iniciales" => "AM"
                "apellidos" => "Torres"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "X2013251409004572"
          "doi" => "10.3265/Nefrologia.2009.29.3.5327.en.full"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409004572?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509004575?idApp=UINPBA000064"
      "url" => "/02116995/0000002900000003/v0_201502091409/X0211699509004575/v0_201502091409/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251409004556"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.2009.29.3.5290.en.full"
    "estado" => "S300"
    "fechaPublicacion" => "2009-06-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2009;29:196-202"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4383
      "formatos" => array:3 [
        "EPUB" => 236
        "HTML" => 3648
        "PDF" => 499
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "titulo" => "FGF23 in chronic kidney disease and kidney post-transplant patients"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "196"
          "paginaFinal" => "202"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "El FGF23 en la insuficiencia renal cr&#243;nica y el post-transplante renal"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig1"
          "etiqueta" => "Fig. 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier Espa&#241;a"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "17018078_f1_p198.jpg"
              "Alto" => 337
              "Ancho" => 398
              "Tamanyo" => 16798
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Armando Luis Negri"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Armando Luis"
              "apellidos" => "Negri"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699509004559"
        "doi" => "10.3265/Nefrologia.2009.29.3.5290.en.full"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509004559?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409004556?idApp=UINPBA000064"
    "url" => "/20132514/0000002900000003/v0_201502091629/X2013251409004556/v0_201502091629/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251409004580"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.2009.29.3.5326.en.full"
    "estado" => "S300"
    "fechaPublicacion" => "2009-06-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2009;29:185-92"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4287
      "formatos" => array:3 [
        "EPUB" => 239
        "HTML" => 3523
        "PDF" => 525
      ]
    ]
    "en" => array:9 [
      "idiomaDefecto" => true
      "titulo" => "Strategies for renal health&#58; a project of the Spanish Society of Nephrology"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "185"
          "paginaFinal" => "192"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "ESTRATEGIAS EN SALUD RENAL&#58; UN PROYECTO DE LA SOCIEDAD ESPA&#209;OLA DE NEFROLOGIA&#46;"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => " Grupo de Acci&#243;n Estrat&#233;gica de la S&#46;E&#46;N&#46;, A Mart&#237;nez Castelao, ALM de Francisco, JL G&#243;rriz, R Alc&#225;zar, L. Orte"
          "autores" => array:6 [
            0 => array:1 [
              "apellidos" => "Grupo de Acci&#243;n Estrat&#233;gica de la S&#46;E&#46;N&#46;"
            ]
            1 => array:2 [
              "Iniciales" => "A"
              "apellidos" => "Mart&#237;nez Castelao"
            ]
            2 => array:2 [
              "nombre" => "ALM"
              "apellidos" => "de Francisco"
            ]
            3 => array:2 [
              "Iniciales" => "JL"
              "apellidos" => "G&#243;rriz"
            ]
            4 => array:2 [
              "Iniciales" => "R"
              "apellidos" => "Alc&#225;zar"
            ]
            5 => array:2 [
              "Iniciales" => "L."
              "apellidos" => "Orte"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699509004583"
        "doi" => "10.3265/Nefrologia.2009.29.3.5326.en.full"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509004583?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409004580?idApp=UINPBA000064"
    "url" => "/20132514/0000002900000003/v0_201502091629/X2013251409004580/v0_201502091629/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "titulo" => "Biobanks&#58; a new tool for clinical research"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "193"
        "paginaFinal" => "195"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "F Lia&#241;o, AM Torres"
        "autores" => array:2 [
          0 => array:3 [
            "Iniciales" => "F"
            "apellidos" => "Lia&#241;o"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:3 [
            "Iniciales" => "AM"
            "apellidos" => "Torres"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Servicio de Nefrología y Departamento de Medicina, 1Biobanco del Hospital Universitario Ramón y Cajal-CIFRA, Madrid, Madrid, España, "
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
          1 => array:3 [
            "entidad" => "Servicio de Nefrología, 1Biobanco del Hospital Universitario Ramón y Cajal-CIFRA, Madrid, Madrid, España, "
            "etiqueta" => "<span class="elsevierStyleSup">b</span>"
            "identificador" => "affb"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Biobancos&#58; una nueva herramienta para la investigaci&#243;n cl&#237;nica"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:8 [
        "identificador" => "fig1"
        "etiqueta" => "Tab.  1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "16918078_t1_p195.jpg"
            "Alto" => 225
            "Ancho" => 826
            "Tamanyo" => 44167
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Difficulties involved in starting up biobanks"
        ]
      ]
    ]
    "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">INTRODUCTION</span></p><p class="elsevierStylePara">Biobank is an establishment containing biological samples that are associated with clinical information&#46; These samples are collected&#44; processed&#44; stored and managed according to quality criteria in order to make them available to serve society in a non-profit way with the aim of promoting biomedical investigation&#46;</p><p class="elsevierStylePara">As we infer from that definition&#44; biobanks are not the active agent for a single centre&#8217;s research&#59; rather&#44; they are complementary tools to facilitate the research of others&#46; Biobanks have come to be in the last five years&#59; their origin lies in the enormous growth of scientific production in biomedicine&#44; the need to coordinate basic and clinical studies by fostering cooperative models&#44; and the possibility of increasing the efficiency of informed consent so that the same biological material may serve for different studies&#46; Naturally&#44; all of this must be done according to criteria ensuring the quality and suitability of the stored samples&#44; and the ethical and legal requirements that guarantee citizens&#8217; rights&#46; Although these factors were already being taken into account be researchers&#44; they were not precisely regulated&#46; The combination of all of the above aspects led to the development of biobanks being considered a top-priority strategic need by both the EEC and&#44; at the Spanish national level&#44; the Carlos III Health Institute&#46;</p><p class="elsevierStylePara">Biobanks are intended to produce wealth through creating a mass of human <span class="elsevierStyleItalic">biological capital</span> intended to foster biomedical research and the promotion of health&#46; Samples must have an <span class="elsevierStyleItalic">overall quality</span> that is not only associated with their collection and storage conditions&#44; but also to their traceability and the precision and reliability of the clinical data associated with those samples&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Present and future of biobanks</span></p><p class="elsevierStylePara">At this time&#44; few biobanks are present in Spain&#46; Due to strategic initiatives by health authorities in this country&#44; an important development is foreseen in the near future&#46; The development of a biobank passes through the following phases&#58; defining its purpose&#44; predicting necessities&#44; obtaining funding&#44; installing infrastructure and preparing techniques&#44; preparing documentation&#44; implementing a management system&#44; and beginning operations&#46; In the medium term&#44; biobanks will begin to function as a network&#44; to maximise their potential on both the national and European levels&#46;</p><p class="elsevierStylePara">Biobanks could be intended to manage the biological material that would be necessary to develop a large project&#44; which would become increasingly associated with a high degree of specialisation &#40;National DNA Bank&#41;&#46; They could also attend to the needs of an institution - a hospital&#44; for example - or they could study a disease&#44; as is the case of the Spanish HIV BioBank&#46; These purposes would not be exclusive&#44; although in the future we would expect a tendency towards a certain degree of specialisation&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Bases for guaranteeing the effectiveness of biobanks</span></p><p class="elsevierStylePara">As mentioned previously&#44; biobanks are a very effective tool at the service of the scientific community&#46; When storing samples on a large scale&#44; complex technical procedures must necessarily be used for sample collection&#44; transport&#44; identification&#44; traceability maintenance&#44; storage at the proper temperature&#44; and for computerised data processing&#44; etc&#46; The bases that will guarantee the effectiveness of biobanks will comprise&#58;</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">Standardisation of procedures</span>&#58; the use of homogeneous&#44; well-defined protocols for sample collection&#44; processing&#44; conservation and storage will guarantee sample quality&#46; Well-defined standard notation of associated data will also create quality clinical information&#46; This will reflect the sample&#8217;s importance as biological capital&#44; since a sample with no associated information lacks value&#46; On the other hand&#44; the fact that the collection and storage of samples and associated clinical data will not be scattered among different groups&#44; centres&#44; collections&#44; etc&#46; will mean that all samples will share the same conditions and will be able to be compared with each other in different studies&#46;</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">Guaranteed sample traceability</span>&#44; by drawing on proper methodology for sample coding and identification&#44; which will guarantee its traceability at all times&#46;</p><p class="elsevierStylePara">- A <span class="elsevierStyleItalic">dynamic</span> and <span class="elsevierStyleItalic">effective management</span> by means of computer applications that allow us to list all of the processes to which samples and associated data have been submitted&#46;</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">The implementation of a quality management system</span> to make the organisation function effectively&#44; improving biobank customer satisfaction&#46;</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">Employment of qualified personnel</span> who will be exclusively dedicated to the operation of the biobank&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Bases for managing biobanks in Spain</span></p><p class="elsevierStylePara">The entire process that takes place from collecting the samples up to their use by researchers must be in accordance with applicable legislation&#44; which for biobanks is principally composed of&#58;</p><p class="elsevierStylePara">- Spanish Law 14&#47;2007 of 3 July regarding biomedical research&#44;<span class="elsevierStyleSup">1</span> which contemplates its origins and regulates its organisation&#44; functioning and records&#46; At present&#44; there is no developmental legislation to clarify it&#44; meaning that we must wait to know what conditions will be necessary for authorisation and for havinga national registry&#46; By law&#44; biobanks must guarantee the quality&#44; safety and traceability of the biological data and samples that they house&#46; Likewise&#44; they must guarantee protection of the rights of subjects who have donated biological material and who may be affected by the research&#46;</p><p class="elsevierStylePara">- <span class="elsevierStyleItalic">Organic Law 15&#47;1999 of 13 December regarding the Protection of Personal Data</span>&#46;<span class="elsevierStyleSup">2</span> This law must be applied to samples from identifiable subjects and to samples for which identification could be re-associated or decoded&#44; which are considered to be personal health-related data&#46; It requires guaranteeing confidentiality and the proper useof samples in the exclusive field of the approved research study&#46; The law does not apply to anonymous or irreversibly dissociated samples&#46;</p><p class="elsevierStylePara">Biobanks may be owned publicly or privately&#44; but for all cases they must be non-profit organisations&#46; Their organisational scheme must contain a scientific director and a file manager&#44; and in addition&#44; they must be attached to two external committees&#58; a scientific committee and an ethics committee&#46;</p><p class="elsevierStylePara">Legal considerations for using biological samples are different for biobanks and sample collections&#46; In both cases&#44; however&#44; the informed consent of the source subject is necessary in order to obtain the samples&#46; Given biobanks&#8217; mission of public service&#44; consent is granted in more wide-ranging terms&#46; This means it is not necessary to give details about the specific project in which the sample is to be used&#44; as would be the case for collections&#59; also&#44; there must be a clause regarding ceding the sample to third parties&#44; which is also impossible for normal data collecting without obtaining further consent&#46;</p><p class="elsevierStylePara">In this way&#44; samples can be kept indefinitely in a biobank and be at the scientific community&#8217;s disposal for future investigations that are not planned atthe moment the sample is taken&#46; The nature of the sample is respected in any case&#46;</p><p class="elsevierStylePara">Samples can be provided at no cost for use in research projects that have been approved by both the scientific and ethics sides&#46;</p><p class="elsevierStylePara">Only the minimum necessary quantity will be ceded&#46; Samples and associated data that are transferred will be kept anonymous or dissociated&#46; In the cession agreement&#44; the researcher will commit to not use the sample for any purpose other than that for which the sample was requested&#46; Likewise&#44; he&#47;she may not cede the sample to third parties&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Who benefits from biobank development&#63;</span></p><p class="elsevierStylePara">We expect that the benefits provided by biobanks will affect various segments of the population&#44; including the following&#58;</p><p class="elsevierStylePara">- Researchers&#58;</p><p class="elsevierStylePara">- Sample quality and organisation criteria allow them to carry out epidemiological studies under proper conditions&#46;<br></br>- Biobanks provide them with legal and ethical assessment and regulate the exchange of biological samples for investigation using standard procedures and transparent workings&#46;<br></br>- Biobanks act as an instrument for cooperative investigation that is multi-centre&#44; interdisciplinary and multi-sectorial&#46;<br></br>- Biobanks contribute to gaining new financing and patents for the Health System&#46;</p><p class="elsevierStylePara">- Patients&#58;</p><p class="elsevierStylePara">- By using biological samples&#44; researchers can develop biomarkers and target treatments that may lead to advances in prediction&#44; early diagnosis and disease treatment methods&#46;</p><p class="elsevierStylePara">- Society in general&#58;</p><p class="elsevierStylePara">- Biobanks may serve to develop diagnostic tools for preventing diseases&#46;<br></br>- They may identify risk factors if studies are carried out relating lifestyles or environmental factors with diseases&#46;<br></br>- The creation of <span class="elsevierStyleItalic">biological capital</span> will foster the creation of social wealth by acting as a factor promoting the development of the pharmaceutical industry&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Other considerations related to biobanks</span></p><p class="elsevierStylePara">Despite the positive aspects that biobanks can contribute&#44; summarised above&#44; their start-up is not free from difficulties&#44; some of which are shown in table 1&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Biobanks and Nephrology</span></p><p class="elsevierStylePara">Our speciality is not unaware of the need to have these tools at our disposal&#44; and in the future they will be completely necessary if we wish to deepen our study of the diseases that concern us&#46; In addition&#44; the possibility of real-time access to samples stored in biobanks will further increase nephrologists&#8217; capacity for research&#46; Given that the SEN &#40;Spanish Society of Nephrology&#41; has been a participative scientific society throughout its history&#44; we are certain that the development of biobanks will lead to better cooperation among us&#44; increasing our research potential&#44; and therefore our contribution to improving care for kidney disease patients&#46; Although we are still in a develop ment phase&#44;<span class="elsevierStyleSup">3</span> we are placing the Ramon y Cajal UH-CIFRA biobank at the disposal of Spanish nephrologists wishing to use it for their projects&#46;</p><p class="elsevierStylePara"><a href="grande&#47;16918078&#95;t1&#95;p195&#46;jpg" class="elsevierStyleCrossRefs"><img src="16918078_t1_p195.jpg" alt="Difficulties involved in starting up biobanks"></img></a></p><p class="elsevierStylePara">Table 1&#46; Difficulties involved in starting up biobanks</p>"
    "pdfFichero" => "P-E-S-A169-EN.pdf"
    "tienePdf" => true
    "multimedia" => array:1 [
      0 => array:8 [
        "identificador" => "fig1"
        "etiqueta" => "Tab.  1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "16918078_t1_p195.jpg"
            "Alto" => 225
            "Ancho" => 826
            "Tamanyo" => 44167
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Difficulties involved in starting up biobanks"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliography"
      "seccion" => array:1 [
        0 => array:1 [
          "bibliografiaReferencia" => array:3 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "LEY 14/2007, de 3 de julio, de Investigación biomédica. BOE 4 julio 2007, núm. 159: pág. 28826"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Ley Orgánica 15/1999, de 13 de diciembre, de Protección de Datos de Carácter Personal. BOE 14 diciembre 1999, núm. 298: pág. 43088"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "AM. Torres, MT. Tenorio, A. Candela, JM. Del Rey, A. Tejedor, L. Boscá, F. Liaño. Creación del Biobanco de Fracaso Renal Agudo de la Comunidad de Madrid: una herramienta para la nefrología española. Nefrología 2008; 28 (supl. 4): 30. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18457558" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000002900000003/v0_201502091629/X2013251409004572/v0_201502091629/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35429"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Editorials"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002900000003/v0_201502091629/X2013251409004572/v0_201502091629/en/P-E-S-A169-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409004572?idApp=UINPBA000064"
]
Article information
ISSN: 20132514
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 8 11 19
2024 October 55 44 99
2024 September 50 31 81
2024 August 60 56 116
2024 July 56 30 86
2024 June 58 28 86
2024 May 47 28 75
2024 April 65 20 85
2024 March 34 19 53
2024 February 63 36 99
2024 January 40 24 64
2023 December 41 26 67
2023 November 56 55 111
2023 October 45 30 75
2023 September 38 30 68
2023 August 39 30 69
2023 July 43 35 78
2023 June 59 22 81
2023 May 80 37 117
2023 April 51 21 72
2023 March 76 31 107
2023 February 44 22 66
2023 January 48 13 61
2022 December 64 37 101
2022 November 79 52 131
2022 October 56 52 108
2022 September 62 31 93
2022 August 67 48 115
2022 July 53 62 115
2022 June 54 30 84
2022 May 87 41 128
2022 April 83 57 140
2022 March 52 56 108
2022 February 59 59 118
2022 January 58 57 115
2021 December 50 43 93
2021 November 48 43 91
2021 October 72 51 123
2021 September 82 44 126
2021 August 79 41 120
2021 July 62 34 96
2021 June 46 18 64
2021 May 66 29 95
2021 April 185 39 224
2021 March 115 33 148
2021 February 138 24 162
2021 January 80 14 94
2020 December 66 6 72
2020 November 82 19 101
2020 October 54 22 76
2020 September 47 17 64
2020 August 52 9 61
2020 July 48 5 53
2020 June 44 14 58
2020 May 77 15 92
2020 April 43 18 61
2020 March 49 11 60
2020 February 65 25 90
2020 January 92 29 121
2019 December 70 17 87
2019 November 60 26 86
2019 October 42 15 57
2019 September 53 14 67
2019 August 36 9 45
2019 July 44 21 65
2019 June 29 10 39
2019 May 33 7 40
2019 April 67 44 111
2019 March 36 15 51
2019 February 12 9 21
2019 January 31 20 51
2018 December 52 26 78
2018 November 64 16 80
2018 October 72 11 83
2018 September 53 8 61
2018 August 36 14 50
2018 July 32 5 37
2018 June 25 9 34
2018 May 33 15 48
2018 April 24 6 30
2018 March 28 7 35
2018 February 24 7 31
2018 January 35 6 41
2017 December 40 11 51
2017 November 25 5 30
2017 October 24 9 33
2017 September 37 10 47
2017 August 31 16 47
2017 July 37 11 48
2017 June 34 9 43
2017 May 33 6 39
2017 April 36 14 50
2017 March 17 14 31
2017 February 29 20 49
2017 January 20 16 36
2016 December 68 12 80
2016 November 86 8 94
2016 October 109 5 114
2016 September 129 5 134
2016 August 163 8 171
2016 July 136 9 145
2016 June 97 0 97
2016 May 105 0 105
2016 April 83 0 83
2016 March 63 0 63
2016 February 93 0 93
2016 January 73 0 73
2015 December 78 0 78
2015 November 90 0 90
2015 October 78 0 78
2015 September 59 0 59
2015 August 66 0 66
2015 July 48 0 48
2015 June 39 0 39
2015 May 59 0 59
2015 April 6 0 6
Show all

Follow this link to access the full text of the article

Idiomas
Nefrología (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?